Medicinal compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 2, 2003
app pub date -
Feb 26, 2003
filing date -
Aug 28, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
This invention relates to drugs that lead to express proteins involved in redox regulation that antagonize oxidative stresses, which elicit inflammation, alleviate inflammation and thus protect living body. This invention provides pharmaceutical compositions containing substances that lead to express, activate or modulate protein, wherein the protein is selected among intravital redox system regulating proteins, ATP synthetases, glyceraldehyde 3-phosphate dehydrogenases, 14-3-3 proteins, phosphatidylethanolamine binding proteins, and the like. Preferably, such a substance includes FTS nonapeptide, which is so-called serum thymic factor. The pharmaceutical compositions of the present invention are useful as drugs that can control oxidative stresses by administering from outside the body.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully